Altamont, NY, United States of America

Dustin Blodgett

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dustin Blodgett. Retrieved from https://idiyas.com/inventor/dustin-blodgett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dustin Blodgett: Inventor in Sterilization Technology

Introduction

Dustin Blodgett is an inventor based in Altamont, New York. His patent work concerns sterilization systems and methods, including technologies relevant to medical products.

Latest Patents

Blodgett is associated with 1 patent, titled “Methods and Systems for Sterilization.” The patent describes systems and methods for applying vaporized chemicals during sterilization and for controlling their distribution, movement, or removal. It includes examples involving vaporized hydrogen peroxide (VHP) for terminal sterilization of medical products.

Career Highlights

Blodgett is associated with Regeneron Pharmaceuticals, Inc. His patent reflects work on processes for managing sterilizing chemicals within sterilization systems.

Collaborations

The provided information identifies Philip Shodder and Dakota Bolt as Blodgett’s coworkers. Their names are included here as professional associations; no specific joint patent work was provided.

Conclusion

Dustin Blodgett’s recorded invention focuses on applying and controlling vaporized chemicals, particularly VHP, in sterilization systems for medical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…